192 related articles for article (PubMed ID: 26309243)
1. Kasabach-Merritt phenomenon in Chinese children: Report of 19 cases and brief review of literature.
Yuan SM; Shen WM; Chen HN; Hong ZJ; Jiang HQ
Int J Clin Exp Med; 2015; 8(6):10006-10. PubMed ID: 26309243
[TBL] [Abstract][Full Text] [Related]
2. Treating kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon by intralesional injection of absolute ethanol.
Shen W; Cui J; Chen J; Zou J; Xiaoying Z
J Craniofac Surg; 2014 Nov; 25(6):2188-91. PubMed ID: 25318440
[TBL] [Abstract][Full Text] [Related]
3. Kasabach-Merritt Phenomenon: Classic Presentation and Management Options.
Mahajan P; Margolin J; Iacobas I
Clin Med Insights Blood Disord; 2017; 10():1179545X17699849. PubMed ID: 28579853
[TBL] [Abstract][Full Text] [Related]
4. The importance of early diagnosis and treatment of kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon.
Vivas-Colmenares GV; Ramirez-Villar GL; Bernabeu-Wittel J; Matute de Cardenas JA; Fernandez-Pineda I
Dermatol Pract Concept; 2015 Jan; 5(1):91-3. PubMed ID: 25692091
[TBL] [Abstract][Full Text] [Related]
5. Case report: Experience of a rare case of rebound of the Kasabach-Merritt phenomenon during sirolimus treatment in kaposiform hemangioendothelioma.
Wang L; Li J; Wu C; Song D; Liu Z; Niu Y; Zhou J; Guo L
Front Pediatr; 2022; 10():949950. PubMed ID: 35990005
[TBL] [Abstract][Full Text] [Related]
6. Kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon in an infant girl.
Helligsø L; Mikkelsen TS; Hvas AM
Clin Case Rep; 2023 Sep; 11(9):e7859. PubMed ID: 37720715
[TBL] [Abstract][Full Text] [Related]
7. Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon in a Neonate - Role of Dual Therapy: A Case Report and Review of Literature.
Parashar G; Shankar G; Sahadev R; Santhanakrishnan R
J Indian Assoc Pediatr Surg; 2020; 25(3):178-181. PubMed ID: 32581448
[TBL] [Abstract][Full Text] [Related]
8. Treatment experience for different risk groups of Kaposiform hemangioendothelioma.
Li M; Wang X; Kieran R; Sun ZW; Gong Y; Lei H; Sun B; Xiao L; Wang Y; Wang S; Li Z; Wang L; Lv R; Xue F; Ge J; Dong C; Huo R
Front Oncol; 2024; 14():1336763. PubMed ID: 38903724
[TBL] [Abstract][Full Text] [Related]
9. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
Cashell J; Smink GM; Helm K; Xavier F
Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
[TBL] [Abstract][Full Text] [Related]
10. Kasabach-merritt phenomenon: case series and retrospective review of the mayo clinic experience.
Rodriguez V; Lee A; Witman PM; Anderson PA
J Pediatr Hematol Oncol; 2009 Jul; 31(7):522-6. PubMed ID: 19564750
[TBL] [Abstract][Full Text] [Related]
11. Episode of Kasabach-Merritt phenomenon following Japanese encephalitis vaccination: Case report.
Yue X; Zhao X; Dai Y; Shu Q
Vaccine; 2017 Dec; 35(48 Pt B):6594-6597. PubMed ID: 29050802
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon.
Fernandez-Pineda I; Lopez-Gutierrez JC; Chocarro G; Bernabeu-Wittel J; Ramirez-Villar GL
Pediatr Blood Cancer; 2013 Sep; 60(9):1478-81. PubMed ID: 23609996
[TBL] [Abstract][Full Text] [Related]
13. Medical management of tumors associated with Kasabach-Merritt phenomenon: an expert survey.
Tlougan BE; Lee MT; Drolet BA; Frieden IJ; Adams DM; Garzon MC
J Pediatr Hematol Oncol; 2013 Nov; 35(8):618-22. PubMed ID: 23774156
[TBL] [Abstract][Full Text] [Related]
14. Kasabach-merritt phenomenon: a retrospective study of treatment with vincristine.
Haisley-Royster C; Enjolras O; Frieden IJ; Garzon M; Lee M; Oranje A; de Laat PC; Madern GC; Gonzalez F; Frangoul H; Le Moine P; Prose NS; Adams DM
J Pediatr Hematol Oncol; 2002; 24(6):459-62. PubMed ID: 12218593
[TBL] [Abstract][Full Text] [Related]
15. Vincristine-ticlopidine-aspirin: an effective therapy in children with Kasabach-Merritt phenomenon associated with vascular tumors.
Fernandez-Pineda I; Lopez-Gutierrez JC; Ramirez G; Marquez C
Pediatr Hematol Oncol; 2010 Nov; 27(8):641-5. PubMed ID: 20863161
[TBL] [Abstract][Full Text] [Related]
16. Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up.
Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S
Pediatr Blood Cancer; 2015 Apr; 62(4):577-80. PubMed ID: 25346262
[TBL] [Abstract][Full Text] [Related]
17. Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options.
Schmid I; Klenk AK; Sparber-Sauer M; Koscielniak E; Maxwell R; Häberle B
World J Pediatr; 2018 Aug; 14(4):322-329. PubMed ID: 30054848
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Therapy for Infant Vascular Tumor Associated With Kasabach-Merritt Phenomenon-Single-Center Primary Experience.
Sun X; Xu M; Lv K; Ma X; Wu L; Ouyang T
Front Pediatr; 2022; 10():924422. PubMed ID: 35813386
[TBL] [Abstract][Full Text] [Related]
19. Residual lesions after Kasabach-Merritt phenomenon in 41 patients.
Enjolras O; Mulliken JB; Wassef M; Frieden IJ; Rieu PN; Burrows PE; Salhi A; Léauté-Labreze C; Kozakewich HP
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):225-35. PubMed ID: 10642677
[TBL] [Abstract][Full Text] [Related]
20. Standards of care for Kasabach-Merritt phenomenon in China.
Yao W; Li KL; Qin ZP; Li K; Zheng JW; Fan XD; Ma L; Zhou DK; Liu XJ; Wei L; Li L; Tai MZ; Wang JH; Ji Y; Zhou L; Huang HJ; Gao XY; Huang ZJ; Gu S; Yang HY
World J Pediatr; 2021 Apr; 17(2):123-130. PubMed ID: 32851561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
